ERIS Lifescience

ERISLIFESCIENCES19 Mar 2024
Pharmaceuticals
+1.15 (+0.14%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in ERIS Lifescience
ERIS Lifescience
Pharmaceuticals
ERISLIFESCIENCES19 Mar 2024
+1.15 (+0.14%)
OverviewFundamentals
1D
1M
6M
1Y
5Y
All

ERIS Lifescience - Share Price & Details

Lowest Today
836.55
Highest Today
850.25
Today’s Open
837.45
Prev. Close
845.9
52 Week High
971.9
52 Week Low
555
Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
47.22%
Upper Circuit
Lower Circuit
P/E TTM
33.03
P/B Ratio
4.69
Traded Value(Cr)
0.39
EPS TTM
25.59
Book value
Dividend
0.87%

Price Performance

-6.06 %
1 Wk
-1.95 %
1 M
-3.92 %
3 M
47.22 %
1 Y
-6.61 %
YTD

Traded Volume Movement

Technical Details

Support 3
826
Support 2
831
Support 1
839
Pivot Point :
845
Resistance 1
853
Resistance 2
859
Resistance 3
867

Reports

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
ERIS Lifesciences Ltd
₹847.05(+1.15/0.14%)
847.05+1.1511,506.6347.2233.034.69
Lupin Ltd
₹1,594.10(-20.30/-1.26%)
1,594.10-20.3073,556.40149.7535.673.81
J B Chemicals & Pharmaceuticals Ltd
₹1,595.00(-16.00/-0.99%)
1,595.00-16.0025,001.8864.7449.349.31
Ipca Laboratories Ltd
₹1,145.75(-19.30/-1.66%)
1,145.75-19.3029,557.8149.1353.724.77
Sanofi India Ltd
₹7,664.65(-145.60/-1.86%)
7,664.65-145.6017,987.0136.6730.4617.71
IOL Chemicals & Pharmaceuticals Ltd
₹404.40(+42.40/11.71%)
404.40+42.402,125.1426.7112.301.34

About ERIS Lifesciences Ltd

ERIS Lifesciences Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 11497.11 crores. It has reported a sales of Rs. 315.96 crores and a net profit of Rs. 31.66 crores for the quarter ended December 2018. The company management includes Amit Indubhushan Bakshi, Amit Indubhushan Bakshi,Kaushal Kamlesh Shah,Inderjeet Singh Negi,Krishnakumar Vaidyanathan,Sujesh Vasudevan,Prashant Gupta,Rajeev Narotam Dalal,Kalpana Unadkat (ERIS Lifesciences Ltd) among others.
Chairman
Amit Indubhushan Bakshi
Registered office
8th Floor Commerce House -IV,Prahladnagar 100 FT Road,Ahmedabad,Gujarat,380015
FAX :91-79-48903474
Background
Incorporation Year2007
Face Value₹1
Market Lot1

Latest News

Nifty 50, Sensex drop about 1% each. Why is Indian stock market down today?
Following weak global Asian stock markets after a trend reversal by the Central Bank of Japan, the Indian stock market witnessed sharp selling pressure during Tuesday deals. The Nifty 50 index opened below the psychological 22,000 mark and went on to touch an intraday low of 21,817 mark, logging an intrada loss of 238 points or more than one percent dip against Monday's closing.
19 Mar 2024 | 12:20 PM
📢 Sensex plunges 310 points at the open; Nifty below 22,000
📈 Amid weak global cues, domestic benchmark indices started gap-down on 19th March, 2024
📢 At 9:16 AM, the Sensex tanked 310 points or 0.43% at 72,437.76, and the Nifty plunged 90 points or 0.41% at 21,965.70.
📊 TCS (⬇️2.59%), Apollo Tyres (⬇️2.64%), and Exide Ind (⬇️2.00%) appeared as the top losers on the Nifty 50 at the Open. L&T Finance, and AU Small Finance stocks are in focus today.
19 Mar 2024 | 09:25 AM
📢 Sensex plunges 310 points at the open; Nifty below 22,000
📈 Amid weak global cues, domestic benchmark indices started down on 19th March, 2024
📢 At 9:16 AM, the Sensex was down by 310 points or 0.43% at 72,437.76, and the Nifty plunged 90 points or 0.41% at 21,965.70.
📊 TCS (⬇️2.59%), Apollo Tyres (⬇️2.64%), and Exide Ind (⬇️2.00%) appeared as the top losers on the Nifty 50 at the Open. L&T Finance, and AU Small Finance stocks are in focus today.
19 Mar 2024 | 09:25 AM
PAT to GDP ratio of smallcaps at 0.7% of GDP has more room for expansion
The Nifty Smallcap 250 index has lost more than 8 percent and the Nifty Midcap 150 index has 5 percent in the past month following a sharp selloff in the broader market. The correction has spooked retail investors even as some buying in select small caps and midcaps are visible. According to a strategy report by ICICI Securities, a “purple patch” is likely in terms of profitability.
19 Mar 2024 | 09:05 AM
Nifty 50, Sensex drop about 1% each. Why is Indian stock market down today?
Following weak global Asian stock markets after a trend reversal by the Central Bank of Japan, the Indian stock market witnessed sharp selling pressure during Tuesday deals. The Nifty 50 index opened below the psychological 22,000 mark and went on to touch an intraday low of 21,817 mark, logging an intrada loss of 238 points or more than one percent dip against Monday's closing.
19 Mar 2024 | 12:20 PM

How to buy ERIS Lifescience shares on nse?

To buy ERIS Lifescience shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the ERIS Lifescience share price today?

The ERIS Lifescience shares price on nse is Rs.847.05 today.

What is the market cap of ERIS Lifescience shares on NSE ?

The company has a market capitalization of Rs.11506.63Cr

What is the PE & PB ratio of ERIS Lifescience shares ?

PE is 33.03 and PB is 4.69

What is the 52 Week High and Low of ERIS Lifescience shares?

ERIS Lifescience stock price high: Rs.971.9 ERIS Lifescience stock price low: Rs.555

What is the price of ERIS Life Sciences stocks on BSE?

The price of ERIS Life Sciences as of the end of day 17th April 2023 was INR 612.6 on BSE.

Is it safe to buy ERIS Life Sciences?

ERIS Life Sciences net profit has increased from Rs. 291.15 crores to Rs. 405.79 crores in the last four years. And the company's sales revenue has grown from Rs.982.6 crores to Rs. 1347 crores in the last four years. 

ERIS Life Sciences stock 52 weeks low is Rs.551.3 and high is Rs.749.8.

Equity investment is a risk like any other investment and it is advisable to take professional advice before investing.  

 

What is the current market value per stock of ERIS Life Sciences?

The current market value (or market capitalization) of ERIS Life Sciences is approximately Rs. 8.33K crores as on 17th April 2023.

Does ERIS Life Science have any debts?

ERIS Life Sciences has a debt-to-equity ratio of 0.13.  

 

Will ERIS Life Science stock price increase?

Eris Life Sciences is a pharmaceutical company based in India that focuses on developing, manufacturing, and marketing branded pharmaceutical products across various therapeutic areas. The company's products are sold in India and other countries, including Nepal, Sri Lanka, and Mauritius.

However, it is near impossible to predict the future movements of stock prices, as they are linked to a wide range of variables, including market trends, economic conditions, company performance, and global events.

It's imperative to conduct thorough research and due diligence in making any investment decisions. And to consider several relevant factors that could impact the company's future prospects.

 

Should I buy or sell ERIS Life Science?

ERIS Life Sciences stock has given a positive return of 33.61%  over the last 3 years and a negative return of -12.85% over the past 12 months.  

Selling or buying of specific stock or stocks depends on your personal financial goals and risk tolerance.